This summary was created by AI, based on 2 opinions in the last 12 months.
The expert reviews suggest that Solventum Corp has recently spun off and dropped its dividend, which led to some concerns among investors. However, the company's recent reports have shown good earnings and a decent valuation. Additionally, the healthcare company Solventum has shown positive organic growth over the past decade, with revenues of $8.2 billion in 2023. Despite some challenges faced by its parent company 3M, Solventum is considered a cheap buy at 11x this year's earnings. Overall, the stock is viewed positively with potential for growth.
She sold it, not because she's negative the stock, but this company spun off and dropped its dividend, and she was holding SOLV for clients in a dividend fund. Their recent reports have actually been good with decent earnings and a decent valuation.
3m completed spinning off healthcare company Solventum today. MMM shares have been challenged by many lawsuits, including over its hearing aids, and some of its businesses have slowed. An exception is Solventum, positing positive organic growth over the past decade. Revenues were $8.2 billion in 2023, but guidance said that 2024 will be a rebuilding year. That said, it's now selling at 11x this year's earnings, cheap. Keep in mind that most spun-offs start off shaky, with those getting initial shares not wanting them. So, buy Solventum gradually over the next 6 months. As for 3M, they paid dearly to settle their lawsuits, so the worst is behind them. Also, they're cutting costs like crazy. Also, Wall Street likes the change in CEOs.
Solventum Corp is a American stock, trading under the symbol SOLV-N on the New York Stock Exchange (SOLV). It is usually referred to as NYSE:SOLV or SOLV-N
In the last year, 1 stock analyst published opinions about SOLV-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Solventum Corp.
Solventum Corp was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Solventum Corp.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Solventum Corp published on Stockchase.
On 2024-12-13, Solventum Corp (SOLV-N) stock closed at a price of $69.56.